Literature DB >> 29198068

Fibroblast growth factor 9 subfamily and the heart.

Shen Wang1, Yong Li2, Chao Jiang3,4, Haishan Tian5.   

Abstract

The fibroblast growth factor (FGF) 9 subfamily is a member of the FGF family, including FGF9, 16, and 20, potentially sharing similar biochemical functions due to their high degree of sequence homology. Unlike other secreted proteins which have a cleavable N-terminal secreted signal peptide, FGF9/16/20 have non-cleaved N-terminal signal peptides. As an intercellular signaling molecule, they are involved in a variety of complex responses in animal development. Cardiogenesis is controlled by many members of the transcription factor family. Evidence suggests that FGF signaling, including the FGF9 subfamily, has a pretty close association with these cardiac-specific genes. In addition, recent studies have shown that the FGF9 subfamily maintains functional adaptation and survival after myocardial infarction in adult myocardium. Since FGF9/16/20 are secreted proteins, their function characterization in cardiac regeneration can promote their potential to be developed for the treatment of cardioprotection and revascularization. Here, we conclude that the FGF9 subfamily roles in cardiac development and maintenance of postnatal cardiac homeostasis, especially cardiac function maturation and functional maintenance of the heart after injury.

Entities:  

Keywords:  Cardiac regeneration; Cardioprotective; Development; Embryonic heart; Fibroblast growth factor 9 subfamily; Myocardial infarction

Mesh:

Substances:

Year:  2017        PMID: 29198068     DOI: 10.1007/s00253-017-8652-3

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  6 in total

1.  Fibroblast growth factor 9 (FGF9) inhibits myogenic differentiation of C2C12 and human muscle cells.

Authors:  Jian Huang; Kun Wang; Lora A Shiflett; Leticia Brotto; Lynda F Bonewald; Michael J Wacker; Sarah L Dallas; Marco Brotto
Journal:  Cell Cycle       Date:  2019-11-18       Impact factor: 4.534

2.  Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor Cells.

Authors:  Karin Jennbacken; Fredrik Wågberg; Ulla Karlsson; Jerry Eriksson; Lisa Magnusson; Marjorie Chimienti; Piero Ricchiuto; Jenny Bernström; Mei Ding; Douglas Ross-Thriepland; Yafeng Xue; Diluka Peiris; Teodor Aastrup; Hanna Tegel; Sophia Hober; Åsa Sivertsson; Mathias Uhlén; Per-Erik Strömstedt; Rick Davies; Lovisa Holmberg Schiavone
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

3.  Soluble Expression of hFGF19 without Fusion Protein through Synonymous Codon Substitutions and DsbC Co-Expression in E. coli.

Authors:  Hye-Ji Choi; Dae-Eun Cheong; Su-Kyoung Yoo; Jaehong Park; Dong-Hyun Lee; Geun-Joong Kim
Journal:  Microorganisms       Date:  2020-12-07

4.  Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway.

Authors:  Yunjie Chen; Ning An; Xuan Zhou; Lin Mei; Yanru Sui; Gen Chen; Huinan Chen; Shengqu He; Cheng Jin; Zhicheng Hu; Wanqian Li; Yang Wang; Zhu Lin; Peng Chen; Litai Jin; Xueqiang Guan; Xu Wang
Journal:  Cell Death Dis       Date:  2022-03-28       Impact factor: 8.469

5.  Phenotypic spectrum of FGF10-related disorders: a systematic review.

Authors:  Katarzyna Bzdega; Justyna A Karolak
Journal:  PeerJ       Date:  2022-09-14       Impact factor: 3.061

Review 6.  Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications.

Authors:  Giovanni Vitale; Alessia Cozzolino; Pasqualino Malandrino; Roberto Minotta; Giulia Puliani; Davide Saronni; Antongiulio Faggiano; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-14       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.